Clinical Trials Browser

Phase 1 × Triple Negative Breast Neoplasms × CLR1404 × Clear all

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01495663 2015-02-26

Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned

BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Recurrence, Sarcoma, Colorectal Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned